STOCK TITAN
  1. Home
  2. News
  3. DRIO

DarioHealth Corp - DRIO STOCK NEWS

Welcome to our dedicated news page for DarioHealth (Ticker: DRIO), a resource for investors and traders seeking the latest updates and insights on DarioHealth.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DarioHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DarioHealth's position in the market.

News
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
Rhea-AI Summary
Blue Shield of California (BSC) (Ticker: BSCA) expands its Wellvolution digital health platform to offer lifestyle medicine programs and introduces Dario, an at-home solution for high blood pressure. The expansion aims to make the platform more accessible to Spanish-speaking members and address the healthcare needs of underserved communities in California.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.24%
Tags
none
-
News
Dario Contracts with New Employer for Cardiometabolic Solution
Rhea-AI Summary
DarioHealth Corp. (DRIO) secures a new contract with a national financial and business services company to provide its cardiometabolic solution to improve the health of its population starting in January 2024. The integrated solution aims to address diabetes, pre-diabetes, weight management, and hypertension, along with support for employees taking GLP-1 medications. Dario combines intelligent technologies and expert human support to deliver personalized experiences and has shown sustainable improvements in clinical outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
Rhea-AI Summary
DarioHealth Corp. (DRIO) announced two new analyses presented by Sanofi U.S. demonstrating improved clinical and economic outcomes associated with the use of Dario's digital health solution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.77%
Tags
none
News
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
Rhea-AI Summary
DarioHealth Corp. (Nasdaq: DRIO) Announces New Study Highlighting the Value of Whole Health Approach for Managing Chronic Conditions and Supporting Members Using GLP-1s
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.8%
Tags
none
-
News
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Rhea-AI Summary
DarioHealth Corp. reported total revenue of $3.52 million in the third quarter of 2023, compared to $6.6 million in the same period last year. The decrease was mainly due to lower commercial strategic partner revenues. However, commercial B2B2C revenues from monthly recurring revenues increased by 19.3% compared to the third quarter of 2022. Dario is on track to launch its behavioral health platform with Aetna in the first quarter of 2024, with multiple employers already committed. The company also expanded its relationship with Aetna and an existing regional plan, and expects to add 15 new customers to its platform in Q1 2024. Dario announced a new agreement with PlanSource to offer its digital health solutions to more than five million consumers. The company ended the quarter with $44 million in cash and cash equivalents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter
Rhea-AI Summary
DarioHealth Corp. has launched a new smart blood sugar meter for Apple iPhone 15 users, providing real-time connectivity for blood sugar readings. The meter is compatible with the iPhone 15's USB-C charging port, allowing for seamless data capture. This innovation reflects Dario's commitment to staying ahead of trends and keeping members engaged.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-21.09%
Tags
none
News
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd
Rhea-AI Summary
DarioHealth Corp. (Nasdaq: DRIO) will release its financial results for Q3 2023 on November 2, 2023. The company will host a conference call and webcast at 8:30am ET. Dial-in number for the conference call is 1-888-886-7786 (domestic) or 1-416-764-8658 (international). Webcast link is https://viavid.webcasts.com/starthere.jsp?ei=1634656&tp_key=1861f55312. A replay of the call will be available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.92%
Tags
conferences earnings
-
News
New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes
Rhea-AI Summary
DarioHealth Corp. announces new research demonstrating a 36% reduction in 30-day hospital readmissions for Dario users compared to non-users with type 2 diabetes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
none
-
News
Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm
Rhea-AI Summary
DarioHealth announces strategic partnership with top employee benefits consulting firm
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.74%
Tags
none
News
DarioHealth to Host Investor Day on The Rise of Digital Health
Rhea-AI Summary
DarioHealth Corp. to host in-person investor day in New York on October 17, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
conferences
Stock DRIO logo
DarioHealth Corp

Nasdaq:DRIO

DRIO Rankings

#4913 Ranked by Market Cap
#5153 Ranked by Stock Gains
N/A Ranked by Dividends

DRIO Stock Data

36.21M
23.92M
14.81%
29.43%
4.63%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
New York

About DRIO

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.